It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and overdose associated with opioids.

The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...

The U.S. Food and Drug Administration (FDA) has approved a new pain pill called Journavx, designed to mitigate the risks of addiction and overdose associated with opioid medications like Vicodin and ...

After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...

The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or ...

The medication offers relatively modest pain relief, underscoring the challenges of finding new ways to manage pain.

The drug offered more relief than a placebo in clinical trials, though it does not appear more effective than other pain ...

Chronic low back pain can disrupt your daily life, keeping you from enjoying family moments, outdoor adventures or even simple tasks like walking or sitting comfortably. If traditional treatments ...

The FDA has approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid ...